Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2022 - 2026)

Atara Biotherapeutics has reported Asset Utilization Ratio for 5 years, with the latest figure at 1.15 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 50.72% year-over-year to 1.15; the trailing twelve-month figure through Mar 2026 stood at 1.15 (down 50.72% YoY), and the FY2025 full-year result was 1.87, up 98.87% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 1.15, down from 4.79 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 4.79 in Q4 2025, with the low at 0.01 in Q2 2023.
• Historically, Asset Utilization Ratio has averaged 1.39 across 5 years, with a median of 0.61 in 2024.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio plunged 67.88% — and 2024, when it surged 5360.82%.
• Atara Biotherapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then sank by 67.88% to 0.05 in 2023, then jumped by 1908.42% to 1.02 in 2024, then surged by 367.94% to 4.79 in 2025, then tumbled by 76.0% to 1.15 in 2026.
• The last three Asset Utilization Ratio figures came in at 1.15 (Q1 2026), 4.79 (Q4 2025), and 4.53 (Q3 2025), per Business Quant data.